Clinical Trials
98 trialsPOEMA
argenx
SAA
University of California, Davis
MG-ARCADIA
AstraZeneca
Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia
AstraZeneca
REAL MG PRO
Centre Hospitalier Universitaire de Nice
MyaRESP
Institut de Myologie, France
TAILOR-MG
IRCCS San Raffaele
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
argenx
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Alexion Pharmaceuticals, Inc.
MY-EDUC
University Hospital, Grenoble
MG Cohort
AstraZeneca
Long-term Efficacy of Modified Guilu Erxian Glue for Myasthenia Gravis
Beijing University of Chinese Medicine
MYCOG
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Alexion Pharmaceuticals, Inc.
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
argenx
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
argenx
EARLY-MG
Centre Hospitalier Universitaire de Nice
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
TREAT-OMG
Tang-Du Hospital
Detecting Fatigue From Voice in Generalised Myasthenia Gravis
Thymia Limited
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Tongji NADs Cohort
Tongji Hospital
PROMPT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Predictors of Myasthenia Gravis Outcome Following Thoracoscopic Thymectomy: Comparative Study Between Thymomatous and Non-Thymomatous Patients
Tanta University
Effectiveness and Safety of Zilucoplan Treatment for French Patients With Myasthenia Gravis Over 3 Months
Centre Hospitalier Universitaire de Nice
The EXPLORE MG Registry for Myasthenia Gravis
Yale University
BioDigit MG-03
BioSensics
BioDigit MG-02
BioSensics
PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
CorEvitas
FBIndex
LMU Klinikum
CAPTURE - MG
Leiden University Medical Center
Construction of A Multimodal Digital Assessment Model for Myasthenia Gravis
Huashan Hospital
OPTIMISE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
VRMG
Vitaccess Ltd
Efgartigimod for Consolidation Therapy in gMG
Da, Yuwei, M.D.
GUIMAUVE
Poitiers University Hospital
A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis
ProgenaBiome
CoRDS
Sanford Health
Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China
Huashan Hospital
Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
University of California, San Francisco
NAD-AIRE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
ZS Associates
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
University Hospital, Clermont-Ferrand
Descriptive Analysis of Real-world Data Collected with ME&MGopen
Ad scientiam
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
ZS Associates
Biomarkers for Fatigue in Patients with Myasthenia Gravis
Leiden University Medical Center
Artificial Intelligence for the Analysis of Video Data of Facial Movement, with a Focus on Myasthenia Gravis
Leiden University Medical Center
EXPLORE-MG2
Yale University
Biomarkers in Autoimmune Disease of Nervous System
Tongji Hospital